The European Commission (EC) has recently set out its draft proposal for adopting an EU-wide health...
Read moreIn June 2018, Remap Consulting had the pleasure of attending the annual National Institute of Health...
Read moreOccupying a senior technical and leadership role in NICE's drug appraisal programme, Meindert has a ...
Read moreSince 2004, opportunity cost has been reflected in NICE's appraisal process through the specificatio...
Read moreThis study investigates NICE evaluations of new cancer indications and legacy CDF indications (not p...
Read moreThis study investigates the efficiency of the new CDF appraisal process for indications without prio...
Read moreThe Association of British Pharmaceutical Industry has been refused a legal challenge to a cap on th...
Read moreThis study investigates NICE's evaluation of existing CDF treatments and its potential impact on fun...
Read moreIncluded in this issue is the implications for the UK market regarding Brexit and how the UKs CDF pe...
Read moreThis process aims to be completely transparent , to enable faster patient access to oncology treatme...
Read more